This post was just published on ZYX Buy Change Alert. NOK has cut its dividend to give it more time to execute a turnaround. The stock is falling on the news. The fall is a buying opportunity. What To Do Now? Those in the stock may continue to hold but not add
It is a sign of the times. Call it a tale of two stocks after earnings. Both Apple (AAPL) and Netflix (NFLX) reported earnings after the close. It is said that a picture is worth 1,000 words. The chart tells the story better than any words can describe. There is a mind boggling 43%
This post was just published on ZYX Short Sell Change Alert. Now there is a fill on FB for a 10% tranche. Consider a stop zone of $33.61 to $33.78.
Apple will report first quarter earnings after the market close today. Apple has become a battleground stock. Earnings will provide lots of data but will not settle the debate about Apple’s future. The obvious question is, “What should investors do with the onslaught of data related to all things Apple?” The
I have been writing for some time that the pace of innovation at Apple was slowing. For a couple of months it was egg on my face as Apple stock continued to skyrocket into the launch of iPhone 5. After iPhone 5 was launched, slowly but surely investors started to recognize that
On Thursday gold staged a bullish ‘outside day.’ In traditional technical analysis, an outside day is traced when the low of the day is lower than the previous day’s low and the high of the day is higher than the previous day’s high. Candlestick or OHLC chart displays make it
(The Weekly Digest reproduces the morning capsules made available every morning before the market open in the Real Time Feeds to the paying subscribers.) CHINA REBOUNDS January 18, 2013 The fourth quarter GDP in China jumped to 7.9% breaking a streak of seven weaker quarters. For the year, China grew
This is a clear bold call to buy Apple in the middle of the doom and gloom that surrounds the stock. However, it is extremely important to buy Apple here the low risk way. The low risk way is to follow the ZYX Change Method. We are in an environment
This post was just published on ZYX Short Sell Change Alert. Initiating a 10% tranche in STJ in the zone of $38.30 to $39.20. The stock as of this writing is $38.39. The street is misunderstanding the FDA letter for this medical device manufacturer. Target zone $31. to $32. Stop zone
This post was just published on ZYX Short Sell Change Alert. Consider short selling a 10% tranche right here around $31.17 to $31.70 on potential disappointment after Facebook announces its new graph search. No stop for the time being. Target zone $27 to $28.